Company profile: Elion Therapeutics
1.1 - Company Overview
Company description
- Provider of biotechnology solutions focused on treating life-threatening IFIs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Elion Therapeutics
Ansun BioPharma
HQ: United States
Website
- Description: Provider of host-directed antivirals and solid tumor therapies. Offers DAS181, a recombinant sialidase that removes sialic acids from respiratory epithelial cells to block viral entry and treat parainfluenza and influenza. Develops multi-modality platforms targeting tumor and immune cells to prevent immune escape and restore tumor surveillance, including oncolytic viruses, bispecific antibodies, and CAR-NK/γδ T cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ansun BioPharma company profile →
Micronics
HQ: United States
Website
- Description: Provider of near-patient in vitro diagnostic products for disease diagnosis, prognosis, and treatment monitoring in the United States and internationally, including the PanNAT molecular diagnostic system, a point-of-care testing instrument.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micronics company profile →
Symbiomix
HQ: United States
Website
- Description: Provider of an anti-infective drug, a single-dose treatment, and innovative medicines for serious women's health infections that have long been neglected; a late-stage, privately held biopharmaceutical company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Symbiomix company profile →
NanoViricides
HQ: United States
Website
- Description: Provider of nanomedicine-based antiviral therapeutics, developing broad-spectrum candidates including NV-387 (RSV, smallpox, mpox, influenza A), NV-CoV-2 for COVID-19 and potentially long COVID (Phase 1a/1b), NV-CoV-2-R with remdesivir, and NV-HHV-1 for shingles rash, leveraging the TheraCour platform and the HerpeCide program for herpes infections (cold sores, genital ulcers, keratitis).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoViricides company profile →
ContraFect
HQ: United States
Website
- Description: Provider of biotechnology research focused on monoclonal antibodies to treat life-threatening infectious diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ContraFect company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Elion Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Elion Therapeutics
2.2 - Growth funds investing in similar companies to Elion Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Elion Therapeutics
4.2 - Public trading comparable groups for Elion Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →